Related references
Note: Only part of the references are listed.Kruppel-like Factor 4 Protein Regulates Isoproterenol-induced Cardiac Hypertrophy by Modulating Myocardin Expression and Activity
Tadashi Yoshida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy
Min Liu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Nkx6.1 regulates islet β-cell proliferation via Nr4a1 and Nr4a3 nuclear receptors
Jeffery S. Tessem et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage
Isil Ozakca et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-?B-dependent transcriptional activity
Shan-Shan Yu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: NUCLEAR HORMONE RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
NR4A nuclear receptors in immunity and atherosclerosis
Anouk A. J. Hamers et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling
Rong-Hao Wang et al.
EMBO MOLECULAR MEDICINE (2013)
Left ventricular mechanical and energetic changes in long-term isoproterenol-induced hypertrophied hearts of SERCA2a transgenic rats
Shinichi Mitsuyama et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein
Magdolna Szanto et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
Xin Luo et al.
GENES & DEVELOPMENT (2012)
Mitochondrial translocation of Nur77 mediates cardiomyocyte apoptosis
Zhaokang Cheng et al.
EUROPEAN HEART JOURNAL (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Deficiency of the NR4A Orphan Nuclear Receptor NOR1 Decreases Monocyte Adhesion and Atherosclerosis
Yue Zhao et al.
CIRCULATION RESEARCH (2010)
A Novel and Orally Active Poly(ADP-Ribose) Polymerase Inhibitor, KR-33889 [2-[Methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic Acid Amide], Attenuates Injury in in Vitro Model of Cell Death and in Vivo Model of Cardiac Ischemia
Kwang-Seok Oh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1
Senthilkumar B. Rajamohan et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
β-Adrenergic signaling regulates NR4A nuclear receptor and metabolic gene expression in multiple tissues
Stephen A. Myers et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation
W. Lee Kraus
CURRENT OPINION IN CELL BIOLOGY (2008)
Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure
Eva Bartha et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Differential Transactivation by Orphan Nuclear Receptor NOR1 and Its Fusion Gene Product EWS/NOR1: Possible Involvement of Poly(ADP-Ribose) Polymerase I, PARP-1
Naganari Ohkura et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
NR4A nuclear orphan receptors: protective in vascular disease?
Thijs W. H. Pols et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Role of Poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: The therapeutic potential of PARP inhibitors
Pal Pacher et al.
CARDIOVASCULAR DRUG REVIEWS (2007)
Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats
Si-Gui Zhou et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy
Jyothish B. Pillai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Poly(ADP-ribose):: novel functions for an old molecule
Valerie Schreiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3β pathway
Anita Palfi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli
LM Pei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cardioprotective effects of poly (ADP-ribose) polymerase inhibition
C Szabó
PHARMACOLOGICAL RESEARCH (2005)
The NR4A subfamily of nuclear receptors:: new early genes regulated by growth factors in vascular cells
J Martínez-González et al.
CARDIOVASCULAR RESEARCH (2005)
Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure
JB Pillai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD+:: application to the high-throughput screening of small molecules as potential inhibitors
KS Putt et al.
ANALYTICAL BIOCHEMISTRY (2004)
Poly(ADP-ribose) polymerase activation in the reperfused myocardium
G Szabó et al.
CARDIOVASCULAR RESEARCH (2004)
The Sir2 family of protein deacetylases
G Blander et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
nor-1 regulates hippocampal axon guidance, pyramidal cell survival, and seizure susceptibility
T Pönniö et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation
J Martínez-González et al.
CIRCULATION RESEARCH (2003)
Sensing DNA damage by PARP-like fingers
S Petrucco
NUCLEIC ACIDS RESEARCH (2003)
The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment
KDSA Wansa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The therapeutic potential of poly(ADP-ribose) polymerase inhibitors
L Virág et al.
PHARMACOLOGICAL REVIEWS (2002)
The nuclear receptor Nor-1 is essential for proliferation of the semicircular canals of the mouse inner ear
T Ponnio et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Share Paper
